Candel Therapeutics, Inc. (NASDAQ:CADL) Most Popular Amongst Individual Investors Who Own 48%, Insiders Hold 30%

Yahoo FinanceSep 13 10:15 ET

Express News | Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to Its Board of Directors

ReutersSep 4 08:00 ET

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Yahoo FinanceSep 3 08:00 ET

Candel Therapeutics | 10-Q: Q2 2024 Earnings Report

SECAug 13 08:32 ET · Announcements

Express News | Candel Therapeutics - on Track for Topline Disease-Free Survival Data From Phase 3 Randomized Controlled Clinical Trial of Can-2409

ReutersAug 13 08:03 ET

Express News | Candel Therapeutics Inc- Sees Existing Cash & Cash Equivalents Will Be Sufficient to Fund Current Operating Plan Into Q1 2025

ReutersAug 13 08:01 ET